{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CVD+Risk", "query": { "condition": "CVD Risk" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 1446, "total_pages": 145, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=CVD+Risk&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T21:33:16.188Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05840081", "title": "Dairy Fat and Fermentation Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Heart Diseases", "Microbial Colonization", "Inflammation" ], "interventions": [ { "name": "Milk or yogurt beverage", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Tufts University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 37, "start_date": "2023-10-01", "completion_date": "2025-08-19", "has_results": false, "last_update_posted_date": "2025-12-12", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05840081" }, { "nct_id": "NCT05469893", "title": "Immuno-PRISM (PRecision Intervention Smoldering Myeloma)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "High-risk Smoldering Multiple Myeloma", "Smoldering Multiple Myeloma", "Multiple Myeloma" ], "interventions": [ { "name": "Teclistamab", "type": "DRUG" }, { "name": "Lenalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Irene Ghobrial, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2022-08-10", "completion_date": "2030-07-31", "has_results": false, "last_update_posted_date": "2026-07-16", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 3, "location_summary": "Denver, Colorado • Boston, Massachusetts • Portland, Oregon", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT05469893" }, { "nct_id": "NCT06903078", "title": "A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Herpes Zoster (HZ)", "Vascular Dementia" ], "interventions": [], "intervention_types": [], "sponsor": "Center for Clinical Studies, Texas", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 375, "start_date": "2025-02-13", "completion_date": "2030-08", "has_results": false, "last_update_posted_date": "2025-12-11", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 2, "location_summary": "Houston, Texas • Webster, Texas", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Webster", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06903078" }, { "nct_id": "NCT07532564", "title": "Risk Factors, Costs, and Impacts of ED Boarding", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Stroke (CVA) or TIA", "Diabetes", "Asthma (Diagnosis)", "COPD (Chronic Obstructive Pulmonary Disease)", "Sepsis", "Hypertension", "Heart Failure", "Pneumonia", "Urinary Tract Infection (Diagnosis)", "Chest Pain", "Psychiatric Disorder", "Sickle Cell Disease (SCD)" ], "interventions": [], "intervention_types": [], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30486, "start_date": "2022-01-01", "completion_date": "2025-12-31", "has_results": true, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07532564" }, { "nct_id": "NCT03246243", "title": "Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hypoxic-Ischemic Encephalopathy", "Hypoglycemia", "Neonatal Abstinence Syndrome" ], "interventions": [ { "name": "nfant feeding solution", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "6 Months", "sex": "ALL", "summary": "Up to 6 Months" }, "enrollment_count": 16, "start_date": "2017-03-29", "completion_date": "2021-05-18", "has_results": false, "last_update_posted_date": "2021-05-21", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03246243" }, { "nct_id": "NCT00134264", "title": "A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Disease", "Diabetes Mellitus" ], "interventions": [ { "name": "torcetrapib/atorvastatin", "type": "DRUG" }, { "name": "atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 15067, "start_date": "2004-07", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2012-02-03", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 95, "location_summary": "Alabaster, Alabama • Birmingham, Alabama • Gilbert, Arizona + 92 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00134264" }, { "nct_id": "NCT02355717", "title": "Role of Cardiometabolic Risk Factors in Childhood Bone Development", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity", "Cardiovascular Disease", "Type 2 Diabetes", "Osteoporosis" ], "interventions": [ { "name": "Observational Study", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Augusta University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "9 Years to 15 Years" }, "enrollment_count": 400, "start_date": "2014-12", "completion_date": "2021-12-30", "has_results": false, "last_update_posted_date": "2019-11-20", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "Augusta, Georgia", "locations": [ { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02355717" }, { "nct_id": "NCT01008384", "title": "The Effect of Vitamin D Repletion on Small Low Density Lipoprotein (LDL) Particle Number in Subjects at Elevated Cardiovascular Risk", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Vitamin D3", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Rockefeller University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 150, "start_date": "2009-10", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2012-06-01", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01008384" }, { "nct_id": "NCT07775976", "title": "Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Cardiovascular Diseases Risk", "Cardiac Conduction System Disease", "Bundle/Fascicular Abnormalities", "His-Purkinje Disease", "Arrhythmias, Cardiac", "Rhythm Phenotypes", "Myocardial Ischemia", "Syncope", "Syncope Recurrent", "Syncope and Collapse", "Seizure Disorder", "Sleep Apnea Syndrome, Obstructive", "Decision Support Systems, Clinical", "Heart Failure - NYHA II - IV", "Heart Failure (for Example, Fluid Overload)", "HRV", "Cardiopulmonary", "Sudden Cardiac Arrest", "Cardiac Arrest (CA)", "Ventricular Arrhythmias and Cardiac Arrest", "Ventricular Fibrillation", "QT Dispersion", "Atrial Cardiomyopathy" ], "interventions": [ { "name": "COR Wearable ECG Monitoring", "type": "DEVICE" }, { "name": "Cor360 Clinician-Facing Decision-Aid Reporting", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Peerbridge Health, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1000, "start_date": "2026-08-20", "completion_date": "2030-06-17", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 2, "location_summary": "Pasadena, California • Nashville, Tennessee", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07775976" }, { "nct_id": "NCT03314974", "title": "Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Leukemia", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Lymphoma", "Chronic Myelogenous Leukemia", "Plasma Cell Leukemia", "Myeloproliferative Neoplasms", "Myelofibrosis", "Myelodysplasia", "Refractory Anemia", "High Risk Anemia", "Chronic Lymphocytic Leukemia", "Small Lymphocytic Lymphoma", "Marginal Zone B-Cell Lymphoma", "Follicular Lymphoma", "Lymphoplasmacytic Lymphoma", "Mantle-Cell Lymphoma", "Prolymphocytic Leukemia", "Diffuse Large Cell Non Hodgkins Lymphoma", "Lymphoblastic Lymphoma", "Burkitt Lymphoma", "High Grade Non-Hodgkin's Lymphoma, Adult", "Multiple Myeloma", "Juvenile Myelomonocytic Leukemia", "Biphenotypic/Undifferentiated/Prolymphocytic Leukemias", "MRD Positive Leukemia", "Natural Killer Cell Malignancies", "Acquired Bone Marrow Failure Syndromes" ], "interventions": [ { "name": "HSCT with TBI Regimen", "type": "BIOLOGICAL" }, { "name": "HSCT with Non-TBI Regimen", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "60 Years", "sex": "ALL", "summary": "Up to 60 Years" }, "enrollment_count": 300, "start_date": "2018-03-30", "completion_date": "2028-06-10", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-04T21:33:16.188Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03314974" } ] }